ArticleOncoTargets and therapy2019
Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells.
Jian Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncoTargets and therapy2019
Jian Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.